[Skip to Content]
[Skip to Content Landing]
Letters
February 13, 2013

Standard-Dose vs High-Dose Multivitamin Supplements for HIV

Author Affiliations
 

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliations: Intramural Research Program, National Institutes of Health, Bethesda, Maryland (spadayatty@gmail.com).

JAMA. 2013;309(6):545-546. doi:10.1001/jama.2012.216991

To the Editor: In the study by Dr Isanaka and colleagues,1 patients with human immunodeficiency virus (HIV) receiving highly active antiretroviral therapy were treated either with standard-dose or high-dose multivitamin supplements, with no difference in outcomes. The authors concluded that high-dose vitamin supplements have no benefit in these patients.

×